OpenAlex
PricingAboutJobs
Log inGet started
Work

Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes

HTML

Year: 2020
Type: article
Source: Nature Metabolism
DOI: 10.1038/s42255-020-0254-1
Authors: Erica P. Cai, Yuki Ishikawa, Wei Zhang, Nayara C. Leite, Jian Li, Shurong Hou, Badr Kiaf, Jennifer Hollister-Lock, Nese Kurt Yilmaz, Celia A. Schiffer, Douglas A. Melton, Stephan Kissler, Peng Yi
Institutions: Joslin Diabetes Center, Harvard University, Harvard Stem Cell Institute, University of Massachusetts Chan Medical School
Language: English

Topic: Diabetes and associated disorders
Subfield: Genetics
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: type 1 diabetes, islet autoimmunity, beta-cell protection, pargyline, cell replacement therapy, disease reversal, therapeutic target
SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, Juvenile Diabetes Research Foundation United States of America, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: G259037166, G2728308995, Functional Validation of Gene Modifications that Protect Beta Cells against Autoimmunity Identified by Genome-Wide CRISPR Cas9 Screening, G492737505, Training Grant in Diabetes and Metabolism, Diabetes Research Center
OpenAlex ID: W3045045289
FWCI: 5.808
Cites: 51
Cited by: 112
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security